According to GlobalData’s company profile on MannKind, Smart inhalers was a key innovation area identified from patents. MannKind's grant share as of September 2023 was 53%. Grant share is based on the ratio of number of grants to total number of patents.

Medicament delivery device with automatic pin movement after time delay

See Also:

Source: United States Patent and Trademark Office (USPTO). Credit: MannKind Corp

A recently granted patent (Publication Number: US11730883B2) describes a medicament delivery device that includes a housing, a medicament chamber, a plunger, a pin, an actuation assembly, and a needle. The housing is designed to hold the components of the device, including the medicament chamber, plunger, and pin. The actuation assembly, which is detachably coupled to the housing, is responsible for moving the pin from a position that prevents movement of the plunger to a position that allows movement of the plunger. This movement occurs after a predetermined time delay, which is set by the actuation assembly.

The actuation assembly consists of an adapter, an activator, and a gear. The adapter is coupled to the pin and includes an internal opening to receive a portion of the pin. It also features a deflectable flange that engages a rim of the pin. The activator is responsible for moving the adapter from a first position to a second position, thereby moving the pin. The gear, which has an internal opening to receive the adapter, allows the adapter to move relative to it.

The medicament delivery device also includes additional features such as a drive gear, an engagement member, a biasing element, an actuator, a timer, an adhesive patch, and a communication module. The drive gear is coupled to the activator and meshes with the gear, allowing the activator to rotate the gear. The engagement member, when in the second position, allows the adapter to move from the first position to the second position. The biasing element urges the engagement member towards the second position. The actuator is responsible for moving the engagement member from the first position to the second position. The timer alerts the user when the device has been activated and when to remove it. The adhesive patch is used to attach the device to the user's skin. The communication module enables communication with a remote device.

The method of operating the medicament delivery device involves attaching the actuation assembly to the device, deploying the needle into the user's skin, and allowing the actuation assembly to move the pin from the first position to the second position after a pre-set time delay. The housing of the device can be coupled to an adhesive patch, which is then adhered to the user's skin.

Overall, this patent describes a medicament delivery device with various components and features that allow for controlled and timed delivery of a medicament, such as insulin, to a user. The device is designed to be single-use and includes mechanisms for activating the device, monitoring dosage, and communicating with external devices.

To know more about GlobalData’s detailed insights on MannKind, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

G lobalDat a, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies